Armodafinil
SIGMA/SML0039 - ≥98% (HPLC)
Synonym: (R)-Modafinil; 2-
CAS Number: 112111-43-0
Empirical Formula (Hill Notation): C15H15NO2S
Molecular Weight: 273.35
MDL Number: MFCD09841055
Linear Formula: C15H15NO2S
Product Type: Chemical
| assay | ≥98% (HPLC) |
| color | white to tan |
| form | powder |
| InChI | 1S/C15H15NO2S/c16-14(17)1 |
| InChI key | YFGHCGITMMYXAQ-LJQANCHMSA |
| optical activity | [α]/D -15 to -20° in methanol (C=1) |
| originator | Teva |
| Quality Level | 100 ![]() |
| SMILES string | NC(=O)CS(=O)C(c1ccccc1)c2 |
| solubility | DMSO: ≥16 mg/mL |
| storage temp. | 2-8°C |
| Application: | Armodafinil may be used in cell signaling studies. |
| Biochem/physiol Actions: | Armodafinil has affinity for dopamine transporters and inhibits the uptake of dopamine in brain areas that are involved in the cognitive performances. It is beneficial for the patients of substance abuse and mental disorders. |
| Biochem/physiol Actions: | Armodafinil is a non-amphetamine, having a half-life of 10−14 hours. |
| Biochem/physiol Actions: | Armodafinil is a psychostimulant wake-promoting agent. |
| Biochem/physiol Actions: | Armodafinil is the R isomer and longer-lasting isomer of racemic modafinil. It is a psychostimulant wake-promoting agent developed for the treatment of narcolepsy, shift work sleep disorder and excessive daytime sleepiness associated with obstructive sleep apnea |
| Features and Benefits: | This compound was developed by Teva . To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here . |
| Symbol | GHS05 |
| Signal word | Danger |
| Hazard statements | H318 |
| Precautionary statements | P280 - P305 + P351 + P338 |
| Hazard Codes | Xi |
| Risk Statements | 41 |
| Safety Statements | 26-39 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥98% (HPLC) |
| Storage Temp. | 2-8°C |
| UNSPSC | 12352200 |


